메뉴 건너뛰기




Volumn 6, Issue 12, 2015, Pages 10532-10547

Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells

Author keywords

Generation; Mechanism; Multiple myeloma; Myeloid derived suppressor cells; Targeting

Indexed keywords

FLUOROURACIL; GR1 NEUTRALIZING ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN BCL 2; PROTEIN MCL 1; STAT3 PROTEIN; UNCLASSIFIED DRUG; MCL1 PROTEIN, HUMAN; MCL1 PROTEIN, MOUSE;

EID: 84929600808     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3300     Document Type: Article
Times cited : (57)

References (47)
  • 4
    • 84861015140 scopus 로고    scopus 로고
    • Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes
    • Rutella S, Locatelli F. Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes. Clin Dev Immunol. 2012; 2012:196063.
    • (2012) Clin Dev Immunol. , vol.2012 , pp. 196063
    • Rutella, S.1    Locatelli, F.2
  • 5
    • 84865606568 scopus 로고    scopus 로고
    • The application and biology of immunomodulatory drugs (IMiDs) in cancer
    • Pan B, Lentzsch S. The application and biology of immunomodulatory drugs (IMiDs) in cancer. Pharmacol Ther. 2012; 136:56-68.
    • (2012) Pharmacol Ther. , vol.136 , pp. 56-68
    • Pan, B.1    Lentzsch, S.2
  • 11
  • 12
    • 84856706929 scopus 로고    scopus 로고
    • Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
    • Filipazzi P, Huber V, Rivoltini L. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother. 2012; 61:255-63.
    • (2012) Cancer Immunol Immunother. , vol.61 , pp. 255-263
    • Filipazzi, P.1    Huber, V.2    Rivoltini, L.3
  • 13
    • 77956920766 scopus 로고    scopus 로고
    • Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells
    • Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. American Association of Immunologists. 2010; 185:2273-84.
    • (2010) J Immunol. American Association of Immunologists. , vol.185 , pp. 2273-2284
    • Lechner, M.G.1    Liebertz, D.J.2    Epstein, A.L.3
  • 15
    • 78650756969 scopus 로고    scopus 로고
    • Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
    • Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 2011; 32:19-25.
    • (2011) Trends Immunol. , vol.32 , pp. 19-25
    • Condamine, T.1    Gabrilovich, D.I.2
  • 16
    • 79953113052 scopus 로고    scopus 로고
    • Transcription factors in myeloid-derived suppressor cell recruitment and function
    • Sonda N, Chioda M, Zilio S, Simonato F, Bronte V. Transcription factors in myeloid-derived suppressor cell recruitment and function. Curr Opin Immunol. 2011; 23:279-85.
    • (2011) Curr Opin Immunol. , vol.23 , pp. 279-285
    • Sonda, N.1    Chioda, M.2    Zilio, S.3    Simonato, F.4    Bronte, V.5
  • 17
    • 27144538568 scopus 로고    scopus 로고
    • Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway
    • Nefedova Y, Nagaraj S, Rosenbauer A, Muro-Cacho C, Sebti SM, Gabrilovich DI. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res. 2005; 65:9525-35.
    • (2005) Cancer Res. , vol.65 , pp. 9525-9535
    • Nefedova, Y.1    Nagaraj, S.2    Rosenbauer, A.3    Muro-Cacho, C.4    Sebti, S.M.5    Gabrilovich, D.I.6
  • 21
    • 84929599172 scopus 로고    scopus 로고
    • Tumor-induced CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients
    • (Dec 30)
    • Wang Z, Zhang L, Wang H, Xiong S, Li Y, Tao Q, Xiao W, Qin H, Wang Y, Zhai Z. Tumor-induced CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients. Cancer Immunol Immunother. 2014; (Dec 30).
    • (2014) Cancer Immunol Immunother.
    • Wang, Z.1    Zhang, L.2    Wang, H.3    Xiong, S.4    Li, Y.5    Tao, Q.6    Xiao, W.7    Qin, H.8    Wang, Y.9    Zhai, Z.10
  • 22
    • 84866636386 scopus 로고    scopus 로고
    • The secret of MIM: a novel, MCL-1-specific small molecule
    • Kritzer JA. The secret of MIM: a novel, MCL-1-specific small molecule. Chem Biol. 2012; 19:1082-3.
    • (2012) Chem Biol. , vol.19 , pp. 1082-1083
    • Kritzer, J.A.1
  • 24
  • 25
    • 84870429906 scopus 로고    scopus 로고
    • Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice
    • Ma C, Kapanadze T, Gamrekelashvili J, Manns MP, Korangy F, Greten TF. Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol. 2012; 92:1199-206.
    • (2012) J Leukoc Biol. , vol.92 , pp. 1199-1206
    • Ma, C.1    Kapanadze, T.2    Gamrekelashvili, J.3    Manns, M.P.4    Korangy, F.5    Greten, T.F.6
  • 27
    • 73249125588 scopus 로고    scopus 로고
    • Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells
    • Ribechini E, Leenen PJM, Lutz MB. Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells. Eur J Immunol. 2009; 39:3538-51.
    • (2009) Eur J Immunol. , vol.39 , pp. 3538-3551
    • Ribechini, E.1    Leenen, P.J.M.2    Lutz, M.B.3
  • 28
    • 84928583389 scopus 로고    scopus 로고
    • Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation
    • De Keersmaecker B, Fostier K, Corthals J, Wilgenhof S, Heirman C, Aerts JL, Thielemans K, Schots R. Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation. Cancer Immunol Immunother. 2014; 63:1023-36.
    • (2014) Cancer Immunol Immunother. , vol.63 , pp. 1023-1036
    • De Keersmaecker, B.1    Fostier, K.2    Corthals, J.3    Wilgenhof, S.4    Heirman, C.5    Aerts, J.L.6    Thielemans, K.7    Schots, R.8
  • 30
    • 84880948301 scopus 로고    scopus 로고
    • Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer
    • Najjar YG, Finke JH. Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer. Front Oncol. 2013; 3:49.
    • (2013) Front Oncol. , vol.3 , pp. 49
    • Najjar, Y.G.1    Finke, J.H.2
  • 31
    • 84891831968 scopus 로고    scopus 로고
    • Sunitinib objective response in metastatic renal cell carcinoma: analysis of 1059 patients treated on clinical trials
    • Molina AM, Lin X, Korytowsky B, Matczak E, Lechuga MJ, Wiltshire R, Motzer RJ. Sunitinib objective response in metastatic renal cell carcinoma: analysis of 1059 patients treated on clinical trials. Eur J Cancer. 2014; 50:351-8.
    • (2014) Eur J Cancer. , vol.50 , pp. 351-358
    • Molina, A.M.1    Lin, X.2    Korytowsky, B.3    Matczak, E.4    Lechuga, M.J.5    Wiltshire, R.6    Motzer, R.J.7
  • 32
    • 84929578181 scopus 로고    scopus 로고
    • Administration Of An Oral PDE5 Inhibitor, Tadalafil In Conjunction With a Lenalidomide Containing Regimen In Patients With Multiple Myeloma-The Myeloma Beacon
    • Ash meeting. p. New Orleans
    • N. Ghosh, L. Rudraraju, X. Ye, K. Noonan, C.A. Huff IB. Administration Of An Oral PDE5 Inhibitor, Tadalafil In Conjunction With a Lenalidomide Containing Regimen In Patients With Multiple Myeloma-The Myeloma Beacon. Ash meeting. p. New Orleans.
    • Ghosh, N.1    Rudraraju, L.2    Ye, X.3    Noonan, K.4    Huff, C.A.I.B.5
  • 35
    • 0025633094 scopus 로고
    • Granulocyte-macrophage colonystimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells
    • Zhang X, Bataille R, Jourdan M, Saeland S, Banchereau J, Mannoni P, Klein B. Granulocyte-macrophage colonystimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood. 1990; 76:2599-605.
    • (1990) Blood. , vol.76 , pp. 2599-2605
    • Zhang, X.1    Bataille, R.2    Jourdan, M.3    Saeland, S.4    Banchereau, J.5    Mannoni, P.6    Klein, B.7
  • 36
    • 77956920766 scopus 로고    scopus 로고
    • Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells
    • Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. 2010; 185:2273-84.
    • (2010) J Immunol. , vol.185 , pp. 2273-2284
    • Lechner, M.G.1    Liebertz, D.J.2    Epstein, A.L.3
  • 38
    • 0037305848 scopus 로고    scopus 로고
    • Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro
    • Manitz M-P, Horst B, Seeliger S, Strey A, Skryabin B V., Gunzer M, Frings W, Schonlau F, Roth J, Sorg C, Nacken W. Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro. Mol Cell Biol. 2003; 23:1034-43.
    • (2003) Mol Cell Biol. , vol.23 , pp. 1034-1043
    • Manitz, M.-P.1    Horst, B.2    Seeliger, S.3    Strey, A.4    Skryabin, B.V.5    Gunzer, M.6    Frings, W.7    Schonlau, F.8    Roth, J.9    Sorg, C.10    Nacken, W.11
  • 39
    • 0033605359 scopus 로고    scopus 로고
    • Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophil. Involvement of Jak2 in the stimulation of phosphatidylinositol 3-kinase
    • Al-Shami A, Naccache PH. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophil. Involvement of Jak2 in the stimulation of phosphatidylinositol 3-kinase. J Biol Chem. 1999; 274:5333-8.
    • (1999) J Biol Chem. , vol.274 , pp. 5333-5338
    • Al-Shami, A.1    Naccache, P.H.2
  • 44
    • 0036659905 scopus 로고    scopus 로고
    • Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells
    • Derenne S. Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells. Blood. 2002; 100:194-9.
    • (2002) Blood. , vol.100 , pp. 194-199
    • Derenne, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.